WASHINGTON, Aug. 4 -- Food and Drug Administration has issued a notice called: Teva Pharmaceuticals USA, Inc, et al.; Withdrawal of Approval of 23 Abbreviated New Drug Applications; Correction.

The notice was published in the Federal Register on Aug. 4 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Registeron January 15, 2025.

For more information, contact Martha Nguyen, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Bldg. 75, Rm. 1676, Silver Spring, MD 20993-0002, 301-796-3471, Martha.Nguyen@fda.hhs.gov.

The full text of the notice can be found...